These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15895004)

  • 1. Incidental finding of ultrasound markers for Down syndrome in the second trimester of pregnancy: a case study.
    Ball JR; Van Riper M; Engstrom JL; Matheson JK
    J Midwifery Womens Health; 2005; 50(3):243-5. PubMed ID: 15895004
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enlarged nuchal translucency with normal karyotype].
    Oueslati A; Amroussi A; Youssef A; Ben Ghezala M; Agrebi W; Ben Mefteh M; Oueslati H
    Tunis Med; 2008 Jun; 86(6):617-8. PubMed ID: 19216466
    [No Abstract]   [Full Text] [Related]  

  • 3. [Down syndrome screening in France: the worst consensus].
    Rozenberg P; Bussières L; Senat MV
    J Gynecol Obstet Biol Reprod (Paris); 2007 Apr; 36(2):95-103. PubMed ID: 17289296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of second-trimester ultrasound in screening for Down syndrome.
    Cuckle H; Maymon R
    Ultrasound Obstet Gynecol; 2013 Mar; 41(3):241-4. PubMed ID: 23460191
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic sonography after first-trimester Down syndrome screening.
    Krantz DA; Hallahan TW; Macri VJ; Macri JN
    Ultrasound Obstet Gynecol; 2007 Jun; 29(6):666-70. PubMed ID: 17492748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome.
    Kadir RA; Economides DL
    Ultrasound Obstet Gynecol; 1997 Apr; 9(4):244-7. PubMed ID: 9168574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice.
    Benacerraf BR
    Prenat Diagn; 2010 Jul; 30(7):644-52. PubMed ID: 20572106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating first-trimester Down syndrome studies into prenatal screening: executive summary of the National Institute of Child Health and Human Development workshop.
    Reddy UM; Mennuti MT
    Obstet Gynecol; 2006 Jan; 107(1):167-73. PubMed ID: 16394055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-trimester sonographic soft markers: what can we learn from the experience of first-trimester nuchal translucency screening?
    Lau TK; Evans MI
    Ultrasound Obstet Gynecol; 2008 Aug; 32(2):123-5. PubMed ID: 18663770
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of first and second trimester aneuploidy risk assessment.
    Reddy UM; Wapner RJ
    Clin Obstet Gynecol; 2007 Jun; 50(2):442-53. PubMed ID: 17513930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Options for Down syndrome screening: what will women choose?
    Grant SS
    J Midwifery Womens Health; 2005; 50(3):211-8. PubMed ID: 15894999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester screening for trisomy 21 using nuchal translucency and nasal bone evaluations in a selected and an unselected population.
    Sonek J; Cicero S; Nicolaides K
    Am J Obstet Gynecol; 2007 Jan; 196(1):e19. PubMed ID: 16996461
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ultrasound in screening for fetal Down syndrome.
    Egan JF
    Curr Womens Health Rep; 2002 Feb; 2(1):52-8. PubMed ID: 12112983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness model for first-trimester versus second-trimester ultrasound screening for Down syndrome.
    Kott B; Dubinsky TJ
    J Am Coll Radiol; 2004 Jun; 1(6):415-21. PubMed ID: 17411619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical aspects of nuchal translucency measurement.
    Abuhamad A
    Semin Perinatol; 2005 Dec; 29(6):376-9. PubMed ID: 16533650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
    Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
    Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
    Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA
    Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.